[
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-05-25",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "Rättelse: Saknad MAR-etikett i tidigare pressmeddelande - Delårsrapport 1 januari - 31 mars 2026",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b0fd2aeec5fb7a9565febc2bcf1d51c52&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aab8a43e74fee5eace7bce8c45a8620f8",
        "date": "2026-05-25",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "05256593.pdf",
        "text_chars": 33267,
        "sha256": "5d82cf9d28de6d24fe2cafdcf299b47e6f69cf52c5ded7e4ce7ab0083547a295",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 33267
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-03-20",
    "title": "Årsredovisning 2025",
    "original_title": "Episurf Medical AB publicerar årsredovisning för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b8f2373a3f89a4541b72925e8667191c5&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a81b93c940a2b2561fb907e5d4868092e",
        "date": "2026-03-20",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "03207922.pdf",
        "text_chars": 284791,
        "sha256": "98f52adea34923f38cbece510aa866da6c82126f0c580e5291cbb9abdb60f0f5",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 179732
          },
          {
            "number": 2,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 105057
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-06",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2025",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bebe861794b68c63db7648158939fc184&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a1bb32b8b6f7e30d498619f54e258bf24",
        "date": "2026-02-06",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "02045726.pdf",
        "text_chars": 43151,
        "sha256": "c388d1c855910f4f5c9ba52e62b0685e49760c8f452685d125a74a427e4870b5",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 43151
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-10-24",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "Delårsrapport 1 januari - 30 september 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b19340b196898e8d63427c8bfb089dcf3&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a60352723909d02bdb354d97cd07a8fe0",
        "date": "2025-10-24",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "10238921.pdf",
        "text_chars": 46826,
        "sha256": "9b9ee7842ea7c3f79acd844498db660d1369325111fd9f9fc529dacb619a69bc",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 46826
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-07-11",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "Delårsrapport 1 januari - 30 juni 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b3b6c3039e428f6bf2dffdea6c6e81996&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a97b92923ca6221d0b7b355374cdf8c11",
        "date": "2025-07-11",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "07108252.pdf",
        "text_chars": 42301,
        "sha256": "fed67fa327fcc0fe2a3c219c8466c92a00c08a61a455f69b30fe40078b228b88",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 42301
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-04-10",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "Delårsrapport 1 januari - 31 mars 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bd069cb94f0918990aafbc4c3995f1bf4&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aa09ea965d322c5501bb7401ee50c54b3",
        "date": "2025-04-10",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "04095665.pdf",
        "text_chars": 39392,
        "sha256": "1c826e86f766fb0916829100e81db6fc31b0edf779f85409a6d3e5c00a2bafd8",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 39392
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-03-06",
    "title": "Årsredovisning 2024",
    "original_title": "Episurf Medical AB publicerar årsredovisning för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b48348410fe68557d1c9726cf5a4e2ba1&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a8a25e81acbd157814da20927ed5b497e",
        "date": "2025-03-06",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "03067038.pdf",
        "text_chars": 284435,
        "sha256": "0d541124ef181df99beb4ec4704da40d9ab287a48f1aeb6b3a6a71caa17206f3",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 178821
          },
          {
            "number": 2,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
            "chars": 105612
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-02-05",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "Bokslutskommuniké 1 januari - 31 december 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bd66d560eb0ef55b36c7c36ebbb7ce8d7&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a1f3af771049d2ccfe7dbfab35a891606",
        "date": "2025-02-05",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "02042157.pdf",
        "text_chars": 41954,
        "sha256": "b5a11beb27fe3efde2a47b3fdd804df75dd2ca4c18fcb40c20d135ddda461477",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 41954
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-10-25",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "Delårsrapport 1 januari - 30 september 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bb9902a842c2af51a0454de22f10b76bb&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a06d68daf7ae64e385c246f482cc074ba",
        "date": "2024-10-25",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "10247432.pdf",
        "text_chars": 44738,
        "sha256": "14fa98a3ab928429690d7871bcf1ae6652f53ccf1e527d17b84206f2ee01c4e6",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 44738
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-07-12",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "DELÅRSRAPPORT 1 JANUARI - 30 JUNI 2024",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b80e29f315ac67e940e6ff2dc5dd86a8c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a6a2d11acb4897d1de569de15eec47bc7",
        "date": "2024-07-12",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "07114860.pdf",
        "text_chars": 41780,
        "sha256": "83eca184a4597906e0794eab275f815da5c0193c770926d1c29368dbf1df2c9a",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 41780
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-04-24",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "DELÅRSRAPPORT 1 JANUARI - 31 MARS 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b1f224de67bca57f2c21c24cd6eaf520c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a7a36e40e82ac82dc2446c736bd9321ad",
        "date": "2024-04-24",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "04236511.pdf",
        "text_chars": 39221,
        "sha256": "b13ec861cf9e4818e4f9fb1e699988603eb9495627c5f2fb55f7860c1d7d8e28",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 39221
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-03-07",
    "title": "Årsredovisning 2023",
    "original_title": "Episurf Medical AB publicerar årsredovisning för 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7c8de5b94e440ab09004ffa3516c8523&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/acbe979e0c81f89598f27cd4285c03d4a",
        "date": "2024-03-07",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "03072581.pdf",
        "text_chars": 288926,
        "sha256": "139cf444afd331abccb74ba0d1f7a563ede9bc0029ddeea094e71af4e3e709a6",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 178677
          },
          {
            "number": 2,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 110247
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-02-09",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2023",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bdf35a0d9eb0277f6313daf14902dcb03&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a52f36b84a728bf9f93a768652b782465",
        "date": "2024-02-09",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "02085164.pdf",
        "text_chars": 40883,
        "sha256": "963175a0cae339404ee7f5d50c015bf3c357bee6ec60876c6ca4685c52b3a9f5",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 40883
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-10-27",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "DELÅRSRAPPORT 1 JANUARI - 30 SEPTEMBER 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b127be84e3c9301d02221e9551be65e28&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a8ba90b376b7b000a0c7f7c1cea1bf132",
        "date": "2023-10-27",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "10263062.pdf",
        "text_chars": 43445,
        "sha256": "159810e20f79e6b8554fc810a4e64c7d5a6b12e079ee0cacc088142454df6ec1",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 43445
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-07-14",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "Delårsrapport 1 januari - 30 juni 2023",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bb0fb3d67258eaddb2e7546c8a2a03740&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a1e9d925eb1bcdc5f8940c8c70a486cb7",
        "date": "2023-07-14",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "07133448.pdf",
        "text_chars": 43490,
        "sha256": "214d155efff34ae01856d9c3f35cef58fd458df12920d8c0a5273e6d334acf8b",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 43490
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-04-28",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "Delårsrapport 1 januari - 31 mars 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b3653d4b260e2aba8f768d542b131dfa3&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aa27343098804155dab684a735ac775fb",
        "date": "2023-04-28",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "04278325.pdf",
        "text_chars": 38866,
        "sha256": "769a8e31fad3c087af20f15ca96f98cfcad5714bbae2ae3146c16b6af816131e",
        "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 38866
          }
        ]
      }
    ],
    "alternatives": []
  }
]